Wells Fargo and Barclays Reassess Oscar Health Amid Rising Medical Costs for 2025
Wells Fargo and Barclays downgrade Oscar Health citing rising medical expenses and pricing concerns for 2025, highlighting potential challenges in sustaining profitability.